Vironova
Advertisement
Articles by Vironova
How Artificial Intelligence Can Address Analytical Challenges in Gene Therapies and Vaccines
ByVironova
Expert panelists share experiences about how to overcome challenges and needs for supporting analytical data in the development of commercial processes for viral-based therapies. How artificial intelligence plays a role in enabling automation for unbiased results to correlate process impact on critical quality attributes. Live: Thursday, Sept. 26, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Sept. 26, 2020 Register free
Advertisement
Latest Updated Articles
- Insights on Purity and Intactness of AAV Gene Therapy Vectors
Published: April 26th 2018 | Updated:
- How Artificial Intelligence Can Address Analytical Challenges in Gene Therapies and Vaccines
Published: September 26th 2019 | Updated:
- Rising Demands for Analytics of Viral Vectors
Published: November 7th 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
2
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
3
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
4
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
5